rs7248104

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.653-39783C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 151,712 control chromosomes in the GnomAD database, including 11,241 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 11241 hom., cov: 30)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.08

Publications

87 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.408 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.653-39783C>T intron_variant Intron 2 of 21 ENST00000302850.10 NP_000199.2
INSRNM_001079817.3 linkc.653-39783C>T intron_variant Intron 2 of 20 NP_001073285.1
INSRXM_011527988.3 linkc.653-39783C>T intron_variant Intron 2 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.653-39783C>T intron_variant Intron 2 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.653-39783C>T intron_variant Intron 2 of 21 1 NM_000208.4 ENSP00000303830.4
INSRENST00000341500.9 linkc.653-39783C>T intron_variant Intron 2 of 20 1 ENSP00000342838.4
INSRENST00000598216.1 linkn.628-39783C>T intron_variant Intron 2 of 9 1

Frequencies

GnomAD3 genomes
AF:
0.379
AC:
57485
AN:
151594
Hom.:
11240
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.306
Gnomad AMI
AF:
0.324
Gnomad AMR
AF:
0.375
Gnomad ASJ
AF:
0.454
Gnomad EAS
AF:
0.315
Gnomad SAS
AF:
0.413
Gnomad FIN
AF:
0.457
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.412
Gnomad OTH
AF:
0.381
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.379
AC:
57510
AN:
151712
Hom.:
11241
Cov.:
30
AF XY:
0.382
AC XY:
28293
AN XY:
74124
show subpopulations
African (AFR)
AF:
0.306
AC:
12630
AN:
41338
American (AMR)
AF:
0.375
AC:
5713
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.454
AC:
1577
AN:
3472
East Asian (EAS)
AF:
0.316
AC:
1625
AN:
5146
South Asian (SAS)
AF:
0.414
AC:
1997
AN:
4820
European-Finnish (FIN)
AF:
0.457
AC:
4785
AN:
10472
Middle Eastern (MID)
AF:
0.405
AC:
119
AN:
294
European-Non Finnish (NFE)
AF:
0.412
AC:
27980
AN:
67936
Other (OTH)
AF:
0.377
AC:
790
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1772
3544
5315
7087
8859
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.402
Hom.:
48056
Bravo
AF:
0.370
Asia WGS
AF:
0.365
AC:
1268
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.4
DANN
Benign
0.73
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7248104; hg19: chr19-7224431; API